Improving Adolescent Sexual Health Outcomes using Health Information Technology
Project Number5R01AI163232-03
Former Number1R01AI163232-01
Contact PI/Project LeaderGOYAL, MONIKA KUMARI
Awardee OrganizationCHILDREN'S RESEARCH INSTITUTE
Description
Abstract Text
Project Abstract
Adolescents account for nearly half of all new sexually transmitted infection (STI) cases annually, and of those,
non-Hispanic Black and Hispanic youth are disproportionately affected. These disparities are attributed, in part,
to differential access to and routine use of quality health care, including STI prevention and treatment. The
overarching goal of our research efforts are to improve adolescent sexual health outcomes and mitigate
disparities in STI rates by leveraging health information technology (HIT) in the emergency department (ED) to
enable detection and treatment of STIs through shared decision making. The objective of this proposal is to
scale and optimize our successful process in improving STI testing rates by leveraging HIT to: 1) seamlessly
integrate broad-scale targeted STI screening through the provision of real-time, electronic health record
embedded, clinical decision support (CDS) based on patient-reported STI-risk assessment into the normal ED
workflow to improve STI detection and 2) use mobile Health (mHealth) to improve STI treatment rates. Building
on our preliminary work, the specific aims are to: 1) use a human factors engineering approach to implement
and optimize a broad-scale computer-facilitated STI screening process into the clinical workflow of the ED; 2)
compare differences in STI detection rates between a sexual health screening (SHS)-derived electronic CDS
strategy versus usual care (no provision of CDS); and 3) compare differences in treatment adherence between
patients receiving text messages versus those receiving usual care (no text messages). Within the first aim, we
will use a human factors engineering approach to conduct workflow analyses which will inform the refinement
of implementation of an STI screening process into the clinical workflow of the ED. In the second aim, we will
conduct a pragmatic trial using an interrupted time series design to measure the impact of SHS-derived
electronic CDS on STI detection rates. In the third aim, we will conduct a randomized clinical trial, nested within
the pragmatic trial, to measure the impact of a two-way text-messaging intervention to improve treatment rates
through identifying and addressing barriers to STI treatment adherence. This innovative approach leverages
HIT to electronically integrate patient-reported sexual risk data to guide CDS and mHealth to improve
treatment adherence. We expect our contribution to help improve sexual health outcomes and reduce
disparities in the burden of STIs among at-risk, vulnerable adolescents by increasing STI detection and
treatment adherence. The proposed work is significant because it has the potential to improve the health of the
millions of adolescents who access EDs as their only source of healthcare and impact national policies related
to STI detection and treatment. In addition, this work can provide proof of concept for leveraging HIT to deliver
patient-centered care with shared decision making to address health care disparities and improve healthcare
quality and outcomes, which can be applied to other types of screening interventions in the future.
Public Health Relevance Statement
Project Narrative
Sexually transmitted infections (STI) disproportionately affect adolescents, and adolescents often rely on
emergency departments (ED) for care. This application proposes to leverage health information technology in
the ED by 1) integrating patient reported outcomes into the electronic health record to drive patient-engaged
clinical decision support for improved STI detection, and 2) using mobile health through two-way text
messaging for improved STI treatment to improve adolescent sexual health outcomes and reduce disparities in
the STI epidemic. The development of an ED-based intervention to tackle the STI epidemic through
implementation of broad screening into the clinical workflow is timely and needed as it may confer significant
public health impact and is consistent with the mission of Healthy People 2030.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Accident and Emergency departmentAcuteAddressAdherenceAdolescentAffectBlack raceCitiesClinicalCommunitiesComputersDataData ReportingDetectionDevelopmentDiagnosisDisparityEffectivenessElectronic Health RecordElectronicsEmergency CareEmergency Department-based InterventionEngineeringEpidemicFrightFutureGeneral PopulationGoalsHealthHealth ServicesHealth Services AccessibilityHealth TechnologyHealthcareHispanicHumanInterruptionInterventionInterviewJudgmentMeasuresMentored Patient-Oriented Research Career Development AwardMissionModelingNot Hispanic or LatinoOutcomePaperPatient Outcomes AssessmentsPatient-Centered CarePatientsPediatric HospitalsPersonsPilot ProjectsPoliciesPopulationPrivacyProcessPublic HealthRandomizedReportingResearchResourcesRiskRisk AssessmentSTI preventionSeriesServicesSexual HealthSexually Transmitted DiseasesSourceSurveysTestingText MessagingTimeTransportationVisitWorkYouthadolescent sexual healthburden of illnessclinical decision supportclinical practicecomputerizedcostdesigndisparity reductionhealth assessmenthealth care availabilityhealth care disparityhealth care qualityhealth disparityhealth information technologyhigh riskhigh risk populationhigh-risk adolescentsimprovedinfection managementinfection rateinnovationinterestmHealthmarginalizationoutcome disparitiespatient engagementpopulation healthpragmatic trialprocess improvementprovider adherencerandomized trialrandomized, clinical trialsrisk stratificationscreeningshared decision makingsocial stigmastemtext messaging interventiontooltreatment adherencetreatment as usualtreatment programtrial designtwo way textingvulnerable adolescent
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
143983562
UEI
M3KHEEYRM1S6
Project Start Date
01-February-2022
Project End Date
31-January-2027
Budget Start Date
01-February-2024
Budget End Date
31-January-2025
Project Funding Information for 2024
Total Funding
$695,471
Direct Costs
$411,193
Indirect Costs
$284,278
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$695,471
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI163232-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI163232-03
Patents
No Patents information available for 5R01AI163232-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI163232-03
Clinical Studies
No Clinical Studies information available for 5R01AI163232-03
News and More
Related News Releases
No news release information available for 5R01AI163232-03
History
No Historical information available for 5R01AI163232-03
Similar Projects
No Similar Projects information available for 5R01AI163232-03